Login
$UNCY
$3.70 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role Source
Shalabh Gupta, M.D. Also a director
President, Chief Executive Officer and Chairman of the Board
53 Not stated
John Townsend
Chief Financial Officer
64 Since 2021
5 years
Pramod Gupta, Ph.D.
EVP, Pharmaceuticals and BD
Title from the Form 4/A dated May 14, 2026
66 Not stated
Doug Jermasek
Executive Vice President, Corporate Strategy
65 Since 2021
5 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 30, 2026 · updated by the 8-K of Sep 29, 2026

Directors
3
serving now
Independent
2 of 2
stated in the proxy; 1 not stated
Average tenure
10.0 years
from year joined
Director Age On board Independent Committees Other public boards 2025 pay Source
Shalabh Gupta
53 2016
10 years
Not stated None stated None stated Paid as CEO
Sandeep Laumas
58 Not stated Independent
Audit Committee · Chair Compensation Committee Nominating and Governance Committee
BioXcel Therapeutics Inc. $154,486
Meredith S. Manning Joined Oct 1, 2026
- - Independent
Audit Committee Compensation Committee Nominating and Corporate Governance Committee · Chair
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support